Related Experiment Video

Updated: Jun 7, 2026

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression
09:25

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Published on: June 28, 2013

Role of Rac1-dependent NADPH oxidase in the growth of pancreatic cancer

J Du1, J Liu, B J Smith

  • 1Department of Radiation Oncology, University of Iowa College of Medicine, Iowa City, IA, USA.

Cancer Gene Therapy
|November 2, 2010
PubMed

Insights

Inhibiting Rac1, a protein linked to K-ras mutations in pancreatic cancer, reduced tumor cell growth and superoxide levels. This suggests Rac1 inhibition is a potential therapeutic strategy for pancreatic cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • K-ras mutations are prevalent in pancreatic cancer (up to 95%).
  • K-ras activates Rac1, leading to NADPH oxidase and superoxide production.
  • Superoxide is crucial for pancreatic cancer cell proliferation and tumor growth.

Purpose of the Study:

  • To investigate the effect of inhibiting Rac1 on pancreatic cancer cell behavior.
  • To determine if Rac1 inhibition impacts Rac1 activity, superoxide levels, and cell proliferation in different pancreatic cell lines.

Main Methods:

  • Utilized human pancreatic cancer cell lines with mutant K-ras (MIA PaCa-2), wild-type K-ras (BxPC-3), and a tumorigenic immortalized cell line (H6c7eR-KrasT).
  • Infected cells with a dominant-negative Rac1 construct (AdN17Rac1).
  • Assessed Rac1 activity, superoxide levels, in vitro cell growth, and tumor growth in xenografts.

Main Results:

  • AdN17Rac1 decreased Rac1 activity, superoxide levels, and inhibited in vitro growth in mutant K-ras cells.
  • AdN17Rac1 did not affect Rac1 activity, superoxide levels, or in vitro growth in wild-type K-ras (BxPC-3) cells.
  • AdN17Rac1 inhibited growth and decreased superoxide in tumorigenic H6c7eR-KrasT cells but not in normal H6c7 cells. Intratumoral injection of AdN17Rac1 inhibited tumor growth in xenografts.

Conclusions:

  • Rac1 activation and subsequent superoxide generation promote pancreatic cancer cell proliferation.
  • Inhibiting Rac1 shows promise as a therapeutic target for pancreatic cancer.
  • The efficacy of Rac1 inhibition is dependent on K-ras mutation status and cell tumorigenicity.

More Related Videos

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Cell Polarization by Rho Proteins01:21

Cell Polarization by Rho Proteins

Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...